Octagon Capital Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Octagon Capital Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.3M	Buy
2024 Q1	–	Sell
2023 Q4	$738K	Buy
2023 Q1	–	Sell
2022 Q4	$1.95M	Hold
2022 Q3	$2.1M	Buy